Johan Szamosi

Extended-Release Quetiapine as Adjunct to an Antidepressant in Patients With Major Depressive Disorder

Michael Bauer, Herman Pretorius, E. Constant et al. · The Journal of Clinical Psychiatry · 2009 · 207 citations

Pharmacy, Pharmacotherapy, Psychiatry +16

Suitability Of Nitisinone In Alkaptonuria 1 (SONIA 1): an international, multicentre, randomised, open-label, no-treatment controlled, parallel-group, dose-response study to investigate the effect of once daily nitisinone on 24-h urinary homogentisic acid excretion in patients with alkaptonuria after 4 weeks of treatment

L. Ranganath, Anna M. Milan, Andrew T. Hughes et al. · Annals of the Rheumatic Diseases · 2014 · 157 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +6

Efficacy and safety of once-daily nitisinone for patients with alkaptonuria (SONIA 2): an international, multicentre, open-label, randomised controlled trial

L. Ranganath, Eftychia Eirini Psarelli, Jean-Baptiste Arnoux et al. · The Lancet Diabetes & Endocrinology · 2020 · 123 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +3

Extended Release Quetiapine Fumarate Monotherapy for Major Depressive Disorder: <i>Results of a Double-Blind, Randomized, Placebo-Controlled Study</i>

Richard H. Weisler, J. Mark Joyce, Lora McGill et al. · CNS Spectrums · 2009 · 106 citations

Medicine, Pharmacology, Psychiatry +17

Multiple Dose Pharmacokinetics of a New Once Daily Extended Release Tolterodine Formulation Versus Immediate Release Tolterodine

Birgitta Olsson, Johan Szamosi · Clinical Pharmacokinetics · 2001 · 85 citations

Pharmacy, Pharmacokinetics, Pharmacology +12